Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-07-2022 | Methotrexate | Case report

Mercaptopurine/methotrexate

Myelodysplastic-syndromes: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Gaur K, et al. Therapy related myelodysplastic syndrome (t-MDS) in childhood Acute lymphoblastic leukemia- an interesting observation. Indian Journal of Pathology and Microbiology 65: 509-510, No. 2, Jun 2022. Available from: URL: http://www.ijpmonline.org/ Gaur K, et al. Therapy related myelodysplastic syndrome (t-MDS) in childhood Acute lymphoblastic leukemia- an interesting observation. Indian Journal of Pathology and Microbiology 65: 509-510, No. 2, Jun 2022. Available from: URL: http://​www.​ijpmonline.​org/​
Metadata
Title
Mercaptopurine/methotrexate
Myelodysplastic-syndromes: case report
Publication date
01-07-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-18872-5

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Mercaptopurine

Case report

Remdesivir

Case report

Antibacterials

Case report

Pembrolizumab